MUSA arrives at today's Q2 earnings release having pulled back from recent highs — but with analyst sentiment distinctly more constructive than it was three months ago.
The stock has drifted lower in the run-up, falling 5.7% on the week and 1.5% in the prior session to close at $580.94, unwinding some of the gains from its one-month 3.6% advance. Options traders aren't reading that pullback as a warning sign. The put/call ratio is running at 0.36, near its 52-week low of 0.34 and well below its 20-day average — calls are outpacing puts, signaling that options positioning remains skewed toward the upside rather than defensively hedged. The borrow market tells the same relaxed story: availability is deep at roughly 3,050% of shares short, meaning the lending pool is barely touched. Short interest ticked up about 1% over the past session to 4.5% of the float, but that follows a 15% decline over the prior month — the weight of short positioning has lightened considerably since late June.
Analyst activity heading into the print has been notably bullish. Goldman Sachs upgraded MUSA to Neutral from Sell in early July, lifting its target from $380 to $550 — a dramatic reversal from the most bearish major-firm stance. Bank of America raised its target to $625, and Jefferies moved to Buy with a $625 target. Wells Fargo followed by bumping its target to $570 while staying at Equal-Weight. The mean consensus target now stands at $630.90, roughly 8.6% above the current price — suggesting the Street sees room to run but isn't unanimously convicted. Bears point to the familiar risks: fuel margin compression without offsetting volume growth, and a capital allocation strategy that has prioritised buybacks over network expansion. That last point carries more weight at $580 than it did at $450 — the dividend yield factor ranks in the 92nd percentile, but the forward earnings growth score sits in just the 22nd percentile, flagging that the valuation is pricing in more than the near-term earnings trajectory currently supports.
One detail from the institutional picture is worth noting. FMR added roughly 89,000 shares through June 30, making it the largest incremental buyer among major holders. BlackRock also added modestly. Against that, insider selling has been the dominant theme on the Form 4 tape: multiple SVPs and two directors sold shares at prices ranging from $511 to $597 across May and June, with net insider value sold running above $30 million over 90 days. Insider selling at these levels doesn't necessarily signal a peak, but it does mean that those closest to the business have been lightening exposure into the same rally that attracted fresh institutional inflows.
The print will test whether the Q2 operating environment — fuel margins, nicotine category performance, and merchandise throughput — can validate a stock that has rallied roughly 50% year-to-date and now trades within sight of a Street consensus that itself was substantially revised upward only weeks ago.
See the live data behind this article on ORTEX.
Open MUSA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
